CNIO researchers discover a new therapy that prevents lung cancer growth in mice

The discovery, which is already being tested in co-clinical trials, brings new clues for the treatment of this disease

2012-08-13

(Press-News.org) Lung cancer is one of the most aggressive types of cancer and the most common cause of death from this disease worldwide. Despite the progress in the molecular biology of lung cancer achieved in recent years, the mechanisms used by tumor cells to grow and spread throughout the body are not yet completely understood. This lack of information is responsible for the limited range of available therapeutic possibilities and their undesirable side effects.

The Tumour Suppression Group of the Spanish National Cancer Research Centre (CNIO), led by Manuel Serrano, has deciphered one of the molecular pathways behind lung cancer. Using this information, the authors have identified an experimental drug, which blocks lung cancer growth in mice. This work is published today in the scientific journal Cancer Cell.

Standing up to lung cancer

Notch was identified in 2004 as an important oncogene for the development of leukemias and, since then, intense efforts have been devoted to study the role of Notch in other cancers. At the end of the last decade it was found that Notch is also involved in the development of pancreatic and lung cancer.

In this study, Serrano's team has identified the molecular pathways by which Notch regulates cell proliferation in lung cancer. "We have found that this protein cooperates with the Ras oncogene, a key element in the formation of these tumors", states Serrano.

Researchers have also discovered the therapeutic effect of a specific experimental drug which blocks Notch efficiently, named GSIs (Gamma-Secretase Inhibitors). To this end, scientists used genetically modified mice previously developed by Mariano Barbacid, head of the Experimental Oncoloy Group at the CNIO, that faithfully recapitulate human lung cancer. "After 15 days of treatment, lung tumors failed to grow without treatment-related side effects", says Antonio Maraver, the first author of the study.

Co-clinical trials both in humans and mice

GSIs were developed over 15 years ago to treat Alzheimer's disease. Although now it is well established that GSIs are not useful to stop this neurodegenerative disease, the discovery that these drugs block Notch has stirred the interest in their possible application for cancer. The accumulated knowledge acquired over the years on the pharmacological properties of GSIs has permitted their immediate use in clinical trials for cancer.

Mouse therapeutic trials performed in parallel with humans clinical trials are called coclinical trials, and are at the cutting edge of biomedical research. These trials allow the transference of information from mice to humans in a very short period of time. A clear example is this research, which is being accompanied by a human clinical trial led by Manuel Hidalgo, director of the Clinical Research Program at the CNIO.

"The assays developed by Serrano led us to believe that blocking Notch could be beneficial for treating lung cancer. We have already treated a dozen patients with an agent directed at the blocking of this protein. We are expanding the study, but I can anticipate that the results are very promising", says Hidalgo.

### Reference article: Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non- small cell lung carcinoma through derepression of DUSP1 phosphatase and inhibition of ERK. Antonio Maraver, Pablo J. Fernández-Marcos, Daniel Herranz, Maribel Muñoz-Martin, Gonzalo Gomez-Lopez, Marta Cañamero, Francisca Mulero, Diego Megías, Marta Sanchez-Carbayo, Jie Shen, Montserrat Sanchez-Cespedes, Teresa Palomero, Adolfo Ferrando, Manuel Serrano. Cancer Cell (2012). doi: 10.1016/j.ccr.2012.06.014

ELSE PRESS RELEASES FROM THIS DATE:

Fruity science halves fat in chocolate

2012-08-13

Scientists have found a way to replace up to 50 per cent of chocolate's fat content with fruit juice. University of Warwick chemists have taken out much of the cocoa butter and milk fats that go into chocolate bars, substituting them with tiny droplets of juice measuring under 30 microns in diameter. They infused orange and cranberry juice into milk, dark and white chocolate using what is known as a Pickering emulsion. Crucially, the clever chemistry does not take away the chocolatey 'mouth-feel' given by the fatty ingredients. This is because the new technique maintains ...

New bacteria-resistant materials discovered

2012-08-13

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures. Medical device associated infections can lead to systemic infections or device failure, costing the NHS £1bn a year. Affecting many commonly used devices including urinary and venous catheters — bacteria form communities known as biofilms. This 'strength in numbers approach' protects them against the bodies' ...

The ins and outs of building the sperm tail

2012-08-13

Sperm swim, lung cells sweep mucus away, and the cells in the female Fallopian tube move eggs from the ovary to the uterus. Underlying these phenomena are flagella – slender, hair-like structures extending from the surface of the cells, that bend, beat or wave rhythmically. In the latest issue of the journal Developmental Cell*, scientists from the Instituto Gulbenkian de Ciência (IGC), in Portugal, have dissected how sperm cells of the fruit fly build their flagella. These findings pave the way to further understand the molecules and processes that may trigger a variety ...

NTU scientist invents pocket living room TV

2012-08-13

Leaving your TV show midway because you had to leave your home will no longer happen as you can now 'pull' the programme on your TV screen onto your tablet and continue watching it seamlessly. You can also watch the same TV show or movie together with your family and friends, no matter which part of the world they are in. Not only that but you'll be able to discuss the show, whether you are on your personal tablet or smart phone, through a channel of your choice, be it video chat, voice or text. The world's first 'pick up and throw back' video feature allows your video ...

Smoking increases, while alcohol consumption may decrease risk of ALS

2012-08-13

A population-based case-control study of the rare but devastating neurological disease amyotrophic lateral sclerosis (ALS) has shown that the risk of such disease is increased among smokers, as has been shown previously. However, surprisingly, the risk of ALS was found to be markedly lower among consumers of alcohol than among abstainers. Forum reviewers thought that this was a well-done and important paper, as it is a population-based analysis, with almost 500 cases of ALS, a very large number of cases for this rare disease. They were especially struck by the magnitude ...

Clemson researchers make optical fibers from common materials

2012-08-13

CLEMSON — Clemson researchers are taking common materials to uncommon places by transforming easily obtainable and affordable materials into fiber. Their findings are published in Nature Photonics, the world's top journal focused on light-based technologies. "We have used a highly purified version of beach sand (silica) for fiber for the last 40 years," said John Ballato, director of the Center for Optical Materials Science and Engineering Technologies at Clemson University. "As a matter of fact, the 2009 Nobel Prize in Physics was awarded for the development of silica ...

BUSM researchers part of multi-center study on cardiac amyloidosis

2012-08-13

(Boston) - Researchers at Boston University School of Medicine (BUSM) have been part of a multicenter observational study called TRACS (Transthyretin Amyloidosis Cardiac Study) to help determine the health significance of a particular gene mutation which is commonly found in Black Americans. The gene, transthyretin (TTR) and the mutation V122I, is seen in about four percent of African Americans or roughly 1.5 million people. The mutation is strongly associated with a condition called cardiac amyloidosis - a disorder where the abnormally mutated TTR protein deposits in ...

The NBA league is more equal than the ACB

2012-08-13

Competitiveness amongst NBA teams is more constant throughout seasons than during the ACB basketball league (Spain), which also falls after every Olympic Games. According to a study from the University of Las Palmas de Gran Canaria, the differences could be attributed to economic and organisational reasons: in the NBA there is just one division, there is a salary cap and the weakest teams have access to good players. The National Basketball Association (NBA) of North America and the Association of Basketball Clubs (ACB) of Spain are the best and most competitive basketball ...

Ancient seal may add substance to the legend of Samson

2012-08-13

Tel Aviv University researchers recently uncovered a seal, measuring 15 millimetres (about a half-inch) in diameter, which depicts a human figure next to a lion at the archaeological site of Beth Shemesh, located between the Biblical cities of Zorah and Eshtaol, where Samson was born, flourished, and finally buried, according to the book of Judges. The scene engraved on the seal, the time period, and the location of the discovery all point to a probable reference to the story of Samson, the legendary heroic figure whose adventures famously included a victory in hand-to-paw ...

AERA et al. bring science to bear in major affirmative action case

2012-08-13

WASHINGTON, August 13, 2012─On August 13, AERA filed an amicus curiae brief in the U.S. Supreme Court case of Fisher v. University of Texas at Austin. The association is joined by seven other scientific societies in urging the Court to consider an overwhelming body of scientific evidence relevant to the case. "AERA has a fundamental interest in the accurate presentation of social science research on these important questions of law. Quite simply, we have a responsibility to enable the Court to make its determinations based on the best scientific evidence available," ...

CNIO researchers discover a new therapy that prevents lung cancer growth in mice

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: